Insurance drug prices of 12 products, such as Avastin and Pegasys, will be voluntarily decreased

Insurance fees of 12 insurance pharmaceutical products, such as the Roche Korea’s antibody, Avastin, will be voluntarily reduced by requests of pharmaceutical manufacturers due to the extension of the benefit standard.

In addition, ceiling price of drugs, such as the BMS Korea’s rheumatoid arthritis treatment, Orencia Inj 250mg, will be adjusted as the usage and drug price negotiation is compl...